Reprint

Novel Aspects of COVID-19 after a Two-Year Pandemic

Edited by
March 2024
158 pages
  • ISBN978-3-7258-0498-6 (Hardback)
  • ISBN978-3-7258-0497-9 (PDF)

This is a Reprint of the Special Issue Novel Aspects of COVID-19 after a Two-Year Pandemic that was published in

Medicine & Pharmacology
Public Health & Healthcare
Summary

The reprint describes all aspects of the fight against SARS-CoV-2- infection (COVID-19). RNA viruses are claimed to be the most common cause of infectious diseases in disasters. Distinguished medical teams in five different countries described their responses to COVID-19 for medically vulnerable people such as HIV-infected persons, the elderly, and cancer-bearing patients. The reprint also encompasses studies of serological, molecular, and image diagnosis of COVID-19. The pathogenic roles of GABA were also proposed.It was also proposed that SARS-CoV-2 infection upregulates GABA, protecting not only the central nervous system, but also the endothelia, pancreas, and gut microbiota. Very rare cases with spontaneous pneumothorax and acute exacerbation after tocilizumab treatment were reported. This reprint teaches effective measures against the ongoing COVID-19 epidemic.

 
Format
  • Hardback
License and Copyright
© 2022 by the authors; CC BY-NC-ND license
Keywords
disaster; infectious diseases; leptospirosis; tuberculosis; dengue; POCT; COVID-19; COVID-19; pneumonia; spontaneous pneumothorax; COVID-19; RNA; Allplex™ 2019-nCoV; TaqPath™ COVID-19; safety of care; n/a; deep learning; COVID-19; explainable artificial intelligence; GABA; SARS-CoV-2; renin–angiotensin system; microbiome; neuropsychiatric disorders; COVID-19; Galectin-9; SARS-CoV-2; acute exacerbation; tocilizumab (TCZ); acute respiratory distress (ARDS); tissue destruction; recover; ADE; COVID-19; coronavirus; laboratory; serum markers; diagnostic accuracy; SARS-CoV-2; palliative; hospice; end-of-life; COVID-19; SARS-CoV-2; COVID-19; SARS-CoV-2; urologic oncology; genitourinary cancer; social determinants of health; COVID-19; long term care facilities; gerocovid observational study; symptoms cluster; ICIs; COVID-19; cancer; mortality; meta-analysis; SARS-CoV-2; COVID-19; Benford’s Law; Singapore; pandemic management; HIV; COVID-19; SARS-CoV-2; complications; outcomes

Related Books

January 2024

COVID-19: Clinical Advances and Challenges

Medicine & Pharmacology
September 2022

Updates in Management of SARS-CoV-2 Infection

Medicine & Pharmacology
January 2024

Clinical Consequences of COVID-19

Medicine & Pharmacology
March 2022

COVID-19: Current Challenges and Future Perspectives

Public Health & Healthcare
...
June 2023

Respiratory Disease in the COVID-19 Era

Medicine & Pharmacology